- Beigene Ltd at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Beigene Ltd Investors and Analysts Panel Event Presentation TranscriptDec 11, 2023
- Beigene Ltd at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Beigene Ltd Investor Research and Development Day TranscriptJul 18, 2023
- Beigene Ltd at Goldman Sachs Global Healthcare Conference TranscriptJun 12, 2023
- Beigene Ltd at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Beigene Ltd to Discuss Final Results of the ALPINE Trial Late-Breaker Presentation TranscriptDec 13, 2022
- Beigene Ltd to Discuss Final Results of the ALPINE Trial Q&A Call TranscriptDec 12, 2022
- Beigene Ltd at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Beigene Ltd at Goldman Sachs Global Healthcare Conference TranscriptJun 14, 2022
- Beigene Ltd at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- Beigene Ltd at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 10, 2022
- Beigene Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Beigene Ltd R&D Day TranscriptAug 25, 2021
- Beigene Ltd to Discuss Interim Analysis of the ALPINE Trial and Data Presented at EHA2021 Call TranscriptJun 11, 2021
- Beigene Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Beigene Ltd China National Reimbursement Drug List (NRDL) Results Conference Call TranscriptDec 29, 2020
- Beigene Ltd at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Beigene Ltd to Discuss the Company's Early Development Pipeline and Research Call TranscriptJul 09, 2020
- Beigene Ltd at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- Beigene Ltd at American Society of Clinical Oncology (ASCO) Virtual Scientific Program Call TranscriptMay 30, 2020
- Beigene Ltd at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Beigene Ltd Update Call: ASPEN Trial Readout TranscriptDec 16, 2019
- Beigene Ltd Corporate Update: Global Strategic Oncology Collaboration with Amgen TranscriptNov 01, 2019
- Beigene Ltd at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Beigene Ltd Update Call TranscriptSep 08, 2019
- Beigene Ltd Conference Call to Discuss Clinical Data on Zanubrutinib at 15th International Conference on Malignant Lymphoma (ICML) TranscriptJun 20, 2019
- Beigene Ltd at Goldman Sachs Global Healthcare Conference TranscriptJun 12, 2019
- Beigene Ltd at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Q4 2018 Beigene Ltd Earnings Call TranscriptFeb 27, 2019€122.52 (+0.96%)Earnings
Beigene Ltd at Morgan Stanley Healthcare Conference Transcript
So great. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Just quickly before we get started, I need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures, so you can pick up a copy at the registration desk.
So pleased to have BeiGene with me for our next session, John Oyler, the CEO; and Howard Liang, CFO. John, I don't know, do you want to make any opening comments? Or should we just jump right into it?
It's great to be here.
Questions & Answers
Okay. Good. So look, I thought we'd start off with just sort of a couple of big picture
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)